Skip to main content
Erschienen in: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 1/2013

01.01.2013 | Leitthema

The 2009 influenza A (H1N1) pandemic

Management and vaccination strategies in The Netherlands

verfasst von: M.A.B. van der Sande, MD MPH PhD, A. Jacobi, A. Meijer, J. Wallinga, W. van der Hoek, M. van der Lubben

Erschienen in: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Prior to 2009, The Netherlands had prepared itself extensively for a potential pandemic. Multidisciplinary guidelines had been drafted to control transmission and limit adverse outcomes for both a phase of early incidental introduction and for a phase with widespread transmission. The Ministry of Health had ensured a supply and distribution schedule for antivirals and negotiated a contract for vaccine purchases. During the pandemic, existing surveillance was expanded, the established infectious disease response structure was activated, and the previously prepared protocols for communication, diagnostics, use of antivirals, and vaccination implementation were operationalized and implemented.
When the pandemic turned out to be less severe than many had anticipated, risk communication and rapid modification of guidelines and communication became a major challenge. Antivirals and pandemic vaccines were reserved for those at high risk for severe outcomes only. Overall, the impact of the pandemic was comparable to the impact of an average seasonal influenza epidemic, but with a shift in (severe) outcomes from the very young and elderly toward young adults. Established prepared protocols enabled timely coordinated responses. In preparing for the worst, sufficient attention must be given to preparing for a mild scenario as well.
Literatur
1.
Zurück zum Zitat Genugten ML van, Heijnen ML, Jager JC (2003) Pandemic Influenza and healthcare demand in the Netherlands: scenario analysis. Emerg Infect Dis 9:531–538PubMedCrossRef Genugten ML van, Heijnen ML, Jager JC (2003) Pandemic Influenza and healthcare demand in the Netherlands: scenario analysis. Emerg Infect Dis 9:531–538PubMedCrossRef
2.
Zurück zum Zitat Hagenaars TJ, van Genugten MLL, Wallinga J (2004) Pandemic influenza and health care demand: dynamic modelling. Int Congr Ser 1263:235–238CrossRef Hagenaars TJ, van Genugten MLL, Wallinga J (2004) Pandemic influenza and health care demand: dynamic modelling. Int Congr Ser 1263:235–238CrossRef
3.
Zurück zum Zitat Koopmans M, Wilbrink B, Conyn M et al (2004) Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587–593PubMedCrossRef Koopmans M, Wilbrink B, Conyn M et al (2004) Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363:587–593PubMedCrossRef
4.
Zurück zum Zitat Asten L van, Lubben M van der, Wijngaard C van den et al (2009) Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. J Clin Virol 45:185–190. (Erratum in: J Clin Virol 2010; 47:204) Asten L van, Lubben M van der, Wijngaard C van den et al (2009) Strengthening the diagnostic capacity to detect Bio Safety Level 3 organisms in unusual respiratory viral outbreaks. J Clin Virol 45:185–190. (Erratum in: J Clin Virol 2010; 47:204)
5.
Zurück zum Zitat Opstelten W, Steenbergen JE van, Essen GA van, Sande MA van der (2009) Threat of an influenza pandemic: family physicians in the front line. BMC Fam Pract 10:11PubMedCrossRef Opstelten W, Steenbergen JE van, Essen GA van, Sande MA van der (2009) Threat of an influenza pandemic: family physicians in the front line. BMC Fam Pract 10:11PubMedCrossRef
6.
Zurück zum Zitat Donker GA, Gravestein J (2007) The best time for flu vaccination. Huisarts en Wetenschap 50:41. (Dutch.) Donker GA, Gravestein J (2007) The best time for flu vaccination. Huisarts en Wetenschap 50:41. (Dutch.)
7.
Zurück zum Zitat Dijkstra F, Donker GA, Wilbrink B et al (2009) Long time trends in influenza-like illness and associated determinants in The Netherlands. Epidemiol Infect 137:473–479PubMedCrossRef Dijkstra F, Donker GA, Wilbrink B et al (2009) Long time trends in influenza-like illness and associated determinants in The Netherlands. Epidemiol Infect 137:473–479PubMedCrossRef
8.
Zurück zum Zitat Enserink R, Meijer A, Dijkstra F et al (2011) Absence of influenza A(H1N1) during seasonal and pandemic seasons in nursing home network. J Am Geriatr Soc 59:2301–2305PubMedCrossRef Enserink R, Meijer A, Dijkstra F et al (2011) Absence of influenza A(H1N1) during seasonal and pandemic seasons in nursing home network. J Am Geriatr Soc 59:2301–2305PubMedCrossRef
9.
Zurück zum Zitat Jonges M, Lubben IM van der, Dijkstra F et al (2009) Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005–2008. Antiviral Res 83:290–297PubMedCrossRef Jonges M, Lubben IM van der, Dijkstra F et al (2009) Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005–2008. Antiviral Res 83:290–297PubMedCrossRef
10.
Zurück zum Zitat Vries E van der, Jonges M, Herfst S et al (2010) Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol 47:34–37PubMedCrossRef Vries E van der, Jonges M, Herfst S et al (2010) Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol 47:34–37PubMedCrossRef
11.
Zurück zum Zitat Dijkstra F, Jonges M, Beek R van et al (2011) Influenza A(H1N1) Oseltamivir resistant viruses in the Netherlands during the winter 2007/2008. Open Virol J 5:154–162PubMedCrossRef Dijkstra F, Jonges M, Beek R van et al (2011) Influenza A(H1N1) Oseltamivir resistant viruses in the Netherlands during the winter 2007/2008. Open Virol J 5:154–162PubMedCrossRef
12.
Zurück zum Zitat Meijer A, Jonges M, Abbink F et al (2011) Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009–2010. Antiviral Res 92:81–89PubMedCrossRef Meijer A, Jonges M, Abbink F et al (2011) Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009–2010. Antiviral Res 92:81–89PubMedCrossRef
13.
Zurück zum Zitat Meijer A, Beerens A, Claas E et al (2009) Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant. J Clin Virol 45:179–184PubMedCrossRef Meijer A, Beerens A, Claas E et al (2009) Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant. J Clin Virol 45:179–184PubMedCrossRef
14.
Zurück zum Zitat Friesema IHF, Meijer A, Gageldonk-Lafeber AF van et al (2012) Coures of pandemic influenza A(H1N1) 2009 virus infection in Dutch patients. Influenza Other Respi Viruses 6:e16–e20CrossRef Friesema IHF, Meijer A, Gageldonk-Lafeber AF van et al (2012) Coures of pandemic influenza A(H1N1) 2009 virus infection in Dutch patients. Influenza Other Respi Viruses 6:e16–e20CrossRef
15.
Zurück zum Zitat Koopmans M, Bruin E de, Godeke GJ et al (2011) Profiling of humoral immune responses to influenza viruses by using protein microarray. Clin Microbiol Infect doi:10.1111/j.1469-0691.2011.03701.x [Epub ahead of print] Koopmans M, Bruin E de, Godeke GJ et al (2011) Profiling of humoral immune responses to influenza viruses by using protein microarray. Clin Microbiol Infect doi:10.1111/j.1469-0691.2011.03701.x [Epub ahead of print]
16.
Zurück zum Zitat Vinck L, Isken L, Hooiveld M et al (2011) Impact of the 2009 influenza A(H1N1) pandemic on public health workers in the Netherlands. Euro Surveill 16:pii19793 Vinck L, Isken L, Hooiveld M et al (2011) Impact of the 2009 influenza A(H1N1) pandemic on public health workers in the Netherlands. Euro Surveill 16:pii19793
17.
Zurück zum Zitat Steens A, Waaijenborg S, Teunis PFM et al (2011) Age-dependent patterns of infection and severity explain the low impact of 2009 influenza A(H1N1): evidence from serial population-based serological surveys. Am J Epidemiol 174:1307–1315PubMedCrossRef Steens A, Waaijenborg S, Teunis PFM et al (2011) Age-dependent patterns of infection and severity explain the low impact of 2009 influenza A(H1N1): evidence from serial population-based serological surveys. Am J Epidemiol 174:1307–1315PubMedCrossRef
18.
Zurück zum Zitat Ferguson NM, Cummings DA, Cauchemez S et al (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437:209–214PubMedCrossRef Ferguson NM, Cummings DA, Cauchemez S et al (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437:209–214PubMedCrossRef
19.
Zurück zum Zitat Ferguson NM, Cummings DA, Fraser C et al (2006) Strategies for mitigating an influenza pandemic. Nature 442:448–452PubMedCrossRef Ferguson NM, Cummings DA, Fraser C et al (2006) Strategies for mitigating an influenza pandemic. Nature 442:448–452PubMedCrossRef
20.
Zurück zum Zitat Lugnér AK, Mylius SD, Wallinga J (2010) Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. Health Econ 19:518–531PubMed Lugnér AK, Mylius SD, Wallinga J (2010) Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic. Health Econ 19:518–531PubMed
21.
Zurück zum Zitat Whelan J, Greenland K, Rondy M et al (2012) Case registry systems for pandemic influenza A(H1N1) in Europe: are there lessons for the future? Euro Surveill 17: pii 20167 Whelan J, Greenland K, Rondy M et al (2012) Case registry systems for pandemic influenza A(H1N1) in Europe: are there lessons for the future? Euro Surveill 17: pii 20167
22.
Zurück zum Zitat Swaan CM, Appels R, Kretzschmar MEE, Steenbergen JE van (2011) Timeliness of contact tracing among flight passengers for influenza A/H1N1 2009. BMC Infect Dis 11:355PubMedCrossRef Swaan CM, Appels R, Kretzschmar MEE, Steenbergen JE van (2011) Timeliness of contact tracing among flight passengers for influenza A/H1N1 2009. BMC Infect Dis 11:355PubMedCrossRef
23.
Zurück zum Zitat Scalia Tomba G, Wallinga JA (2008) Simple explanation for the low impact of border control as a countermeasure to the spread of an infectious disease. Math Biosci 214:70–72CrossRef Scalia Tomba G, Wallinga JA (2008) Simple explanation for the low impact of border control as a countermeasure to the spread of an infectious disease. Math Biosci 214:70–72CrossRef
24.
Zurück zum Zitat Boven M van, Donker T, Lubben M van der et al (2010) Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis. PLoS One 5:e11442PubMedCrossRef Boven M van, Donker T, Lubben M van der et al (2010) Transmission of novel influenza A(H1N1) in households with post-exposure antiviral prophylaxis. PLoS One 5:e11442PubMedCrossRef
25.
Zurück zum Zitat Vriend HJ, Hahne SJM, Donker T et al (2009) The new influenza A(H1N1)-epidemic in the Netherlands (in Dutch). Ned Tijdschr Geneeskd 153:A969 Vriend HJ, Hahne SJM, Donker T et al (2009) The new influenza A(H1N1)-epidemic in the Netherlands (in Dutch). Ned Tijdschr Geneeskd 153:A969
26.
Zurück zum Zitat Hahné S, Donker T, Meijer A et al (2009) Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill 14:pii:19267 Hahné S, Donker T, Meijer A et al (2009) Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill 14:pii:19267
27.
Zurück zum Zitat Dissel JT van, Coutinho RA, Sande MAB van der (2009) Neuraminidase inhibitors for increased risk of influenza complications: balanced and supported advice. Ned Tijdschr Geneeskd 153:B486. (Dutch.)PubMed Dissel JT van, Coutinho RA, Sande MAB van der (2009) Neuraminidase inhibitors for increased risk of influenza complications: balanced and supported advice. Ned Tijdschr Geneeskd 153:B486. (Dutch.)PubMed
28.
Zurück zum Zitat Donker T, van Boven M, van Ballegooijen WM et al (2011) Nowcasting pandemic influenza (H1N1)2009 hospitalisations in the Netherlands. Eur J Epidemiol 26:195–201PubMedCrossRef Donker T, van Boven M, van Ballegooijen WM et al (2011) Nowcasting pandemic influenza (H1N1)2009 hospitalisations in the Netherlands. Eur J Epidemiol 26:195–201PubMedCrossRef
29.
Zurück zum Zitat Cauchemez S, Ferguson NM, Wachtel C et al (2009) Closure of schools during an influenza pandemic. Lancet Infect Dis 9:473–481PubMedCrossRef Cauchemez S, Ferguson NM, Wachtel C et al (2009) Closure of schools during an influenza pandemic. Lancet Infect Dis 9:473–481PubMedCrossRef
30.
Zurück zum Zitat Wallinga J, Boven M van, Lipsitch M (2010) Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci U S A 107:923–928PubMedCrossRef Wallinga J, Boven M van, Lipsitch M (2010) Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci U S A 107:923–928PubMedCrossRef
31.
Zurück zum Zitat Weerd W van der, Timmermans DR, Beaujean DJ et al (2011) Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in The Netherlands. BMC Public Health 11:575PubMedCrossRef Weerd W van der, Timmermans DR, Beaujean DJ et al (2011) Monitoring the level of government trust, risk perception and intention of the general public to adopt protective measures during the influenza A (H1N1) pandemic in The Netherlands. BMC Public Health 11:575PubMedCrossRef
32.
Zurück zum Zitat Klooster T van ‘t, Wielders CC, Donker T et al (2010) Surveillance of Hospitalisations for 2009 Pandemic Influenza A(H1N1) in the Netherlands, 5 June—31 December 2009. Euro Surveill 15:pii:19461 Klooster T van ‘t, Wielders CC, Donker T et al (2010) Surveillance of Hospitalisations for 2009 Pandemic Influenza A(H1N1) in the Netherlands, 5 June—31 December 2009. Euro Surveill 15:pii:19461
33.
Zurück zum Zitat Gageldonk-Lafeber AB van, Riesmeijer RM, Friesema IHM et al (2011) Case-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009–2010 pandemic season versus the 2010–2011 influenza season. BMC Public Health 11:758PubMedCrossRef Gageldonk-Lafeber AB van, Riesmeijer RM, Friesema IHM et al (2011) Case-based reported mortality associated with laboratory-confirmed influenza A(H1N1) 2009 virus infection in the Netherlands: the 2009–2010 pandemic season versus the 2010–2011 influenza season. BMC Public Health 11:758PubMedCrossRef
34.
Zurück zum Zitat Wijngaard CC van den, Asten L van, Koopmans M et al (2012) Comparing pandemic to seasonal influenza mortality: Moderate impact overall but high mortality in young children. PloS One 7:e31197PubMedCrossRef Wijngaard CC van den, Asten L van, Koopmans M et al (2012) Comparing pandemic to seasonal influenza mortality: Moderate impact overall but high mortality in young children. PloS One 7:e31197PubMedCrossRef
35.
Zurück zum Zitat Gageldonk AB van, Hooiveld M, Meijer A et al (2011) The relative clinical impact of 2009 pandemic influenza A(H1N1) in the community compared to seasonal influenza in the Netherlands was most marked among 5–14 year olds. Influenza Other Respi Viruses 5:e513–e520CrossRef Gageldonk AB van, Hooiveld M, Meijer A et al (2011) The relative clinical impact of 2009 pandemic influenza A(H1N1) in the community compared to seasonal influenza in the Netherlands was most marked among 5–14 year olds. Influenza Other Respi Viruses 5:e513–e520CrossRef
36.
Zurück zum Zitat De Jong JC, Rimmelzwan GF, Donker GA et al (2001) The Mexican flu pandemic of 2009: an overview with a focus on the Netherlands. Ned Tijdsch Med Microbiol 19:6–12. (Dutch.) De Jong JC, Rimmelzwan GF, Donker GA et al (2001) The Mexican flu pandemic of 2009: an overview with a focus on the Netherlands. Ned Tijdsch Med Microbiol 19:6–12. (Dutch.)
37.
Zurück zum Zitat Wielders CC, Lier EA van, Klooster TM van ‘t et al (2012) The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health 22:150–157PubMedCrossRef Wielders CC, Lier EA van, Klooster TM van ‘t et al (2012) The burden of 2009 pandemic influenza A(H1N1) in the Netherlands. Eur J Public Health 22:150–157PubMedCrossRef
38.
Zurück zum Zitat Looijmans-van den Akker I, Delden JJ van, Hak E (2007) Uptake of influenza vaccination in Dutch nursing home personnel following national recommendations. J Am Geriatr Soc 55:1486–1487CrossRef Looijmans-van den Akker I, Delden JJ van, Hak E (2007) Uptake of influenza vaccination in Dutch nursing home personnel following national recommendations. J Am Geriatr Soc 55:1486–1487CrossRef
39.
Zurück zum Zitat Opstelten W, Essen GA van, Heijnen ML et al (2010) High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice. Vaccine 28:6164–6168PubMedCrossRef Opstelten W, Essen GA van, Heijnen ML et al (2010) High vaccination rates for seasonal and pandemic (A/H1N1) influenza among healthcare workers in Dutch general practice. Vaccine 28:6164–6168PubMedCrossRef
40.
Zurück zum Zitat Van Lier A, Steens A, Ferreira JA et al (2012) Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine 30:2892–2899CrossRef Van Lier A, Steens A, Ferreira JA et al (2012) Acceptance of vaccination during pregnancy: experience with 2009 influenza A (H1N1) in the Netherlands. Vaccine 30:2892–2899CrossRef
41.
Zurück zum Zitat Greeff SC de, Melker HE de, Spanjaard L et al (2003) The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients. Ned Tijdschr Geneeskd 147:1132–1135. (Dutch.)PubMed Greeff SC de, Melker HE de, Spanjaard L et al (2003) The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients. Ned Tijdschr Geneeskd 147:1132–1135. (Dutch.)PubMed
42.
Zurück zum Zitat Hanquet G, Damme P van, Brasseur D et al (2010) Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine 29:370–377PubMedCrossRef Hanquet G, Damme P van, Brasseur D et al (2010) Lessons learnt from pandemic A(H1N1) 2009 influenza vaccination. Highlights of a European workshop in Brussels (22 March 2010). Vaccine 29:370–377PubMedCrossRef
43.
Zurück zum Zitat Tacken M, Mulder J, Visscher S et al (2010) Monitoring vaccination uptake Dutch National Program Influenza Prevention 2009. LINH, IQ Healthcare, Nijmegen Tacken M, Mulder J, Visscher S et al (2010) Monitoring vaccination uptake Dutch National Program Influenza Prevention 2009. LINH, IQ Healthcare, Nijmegen
44.
Zurück zum Zitat Steens A, Hoek W van der, Dijkstra F, Sande M van der (2011) Influenza vaccine effectiveness, 2010/11. Euro Surveill 16:pii19843 Steens A, Hoek W van der, Dijkstra F, Sande M van der (2011) Influenza vaccine effectiveness, 2010/11. Euro Surveill 16:pii19843
45.
Zurück zum Zitat Steens A, Wijnans EG, Dieleman JP et al (2011) Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study. BMC Infect Dis 11:196PubMedCrossRef Steens A, Wijnans EG, Dieleman JP et al (2011) Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study. BMC Infect Dis 11:196PubMedCrossRef
46.
Zurück zum Zitat Stein ML, Vliet JA van, Timen A (2011) Chronological overview of the 2009/2010 H1N1 influenza pandemic and the response of the Centre for Infectious Disease Control RIVM. Bilthoven; RIVM Report 215011006/2011 Stein ML, Vliet JA van, Timen A (2011) Chronological overview of the 2009/2010 H1N1 influenza pandemic and the response of the Centre for Infectious Disease Control RIVM. Bilthoven; RIVM Report 215011006/2011
47.
Zurück zum Zitat Weeramanthri TS, Robertson AG, Dowse GK et al (2010) Response to pandemic (H1N1)2009 influenza in Australia—lessons from a State health department perspective. Aust Health Rev 34:477–486PubMedCrossRef Weeramanthri TS, Robertson AG, Dowse GK et al (2010) Response to pandemic (H1N1)2009 influenza in Australia—lessons from a State health department perspective. Aust Health Rev 34:477–486PubMedCrossRef
Metadaten
Titel
The 2009 influenza A (H1N1) pandemic
Management and vaccination strategies in The Netherlands
verfasst von
M.A.B. van der Sande, MD MPH PhD
A. Jacobi
A. Meijer
J. Wallinga
W. van der Hoek
M. van der Lubben
Publikationsdatum
01.01.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz / Ausgabe 1/2013
Print ISSN: 1436-9990
Elektronische ISSN: 1437-1588
DOI
https://doi.org/10.1007/s00103-012-1582-4

Weitere Artikel der Ausgabe 1/2013

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 1/2013 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Isotretinoin: Risiko für schwere Laboranomalien „marginal erhöht“

08.05.2024 Akne Nachrichten

Die Aknetherapie mit Isotretinoin kann einen Anstieg von Leberenzymen und Blutfetten verursachen. Das Risiko für schwere Störungen ist laut einer Forschungsgruppe der Universität Lübeck aber nur marginal erhöht und auf einen engen Zeitraum konzentriert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.